Association of mycobacterial antigen-specific CD4+ memory T cell subsets with outcome of pulmonary tuberculosis

Journal of Infection

Volumn 60, Issue 2, 2010, Pages 133-139

  Wang, Xinjing ^a   Cao, Zhihong ^a   Jiang, Jing ^a   Niu, Hanjie ^a   Dong, Mei ^a   Tong, Aihua ^a   Cheng, Xiaoxing ^a  

^a 309TH HOSPITAL OF PLA   (China)

Author keywords

Flow cytometry; Memory T cells; Pulmonary tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; CD40 LIGAND; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; MYCOBACTERIUM ANTIGEN; TUBERCULOSTATIC AGENT;

ADULT; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIUM CULTURE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG TUBERCULOSIS; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; SPUTUM SMEAR; T LYMPHOCYTE SUBPOPULATION; TREATMENT DURATION;

ADULT; ANTIGENS, BACTERIAL; ANTIGENS, CD45; ANTITUBERCULAR AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CCR7; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 75549086667     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.10.048     Document Type: Article

References (31)

1. WHO Global tuberculosis control: epidemiology, strategy, financing 2009, WHO report, WHO.
2. Kaufmann S.H.E. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis 2002, 61(Suppl. II):ii54-ii58.
3. van Crevel R., Ottenhoff T.H., van der Meer J.W. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002, 15:294-309.
4. +4 T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 2008, 180:1962-1970.
5. +8 T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 2009, 119:1167-1177.
6. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
7. +4 T cell subsets and their differentiation. Int Immunol 2008, 20:1189-1199.
8. Lanzavecchia A., Sallusto F. Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 2005, 17:326-332.
9. +4 T cells and the development of central memory during Mycobacterium tuberculosis infection. J Immunol 2006, 177:6361-6369.
10. Caccamo N., Meraviglia S., La Mendola C., Guggino G., Dieli F., Salerno A. Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. J Immunol 2006, 177:1780-1785.
11. Caccamo N., Guggino G., Meraviglia S., Gelsomino G., Di Carlo P., Titone L., et al. Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection. PLoS One 2009, 4:e5528.
12. +4 memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis 2006, 194:984-992.
13. +4 T lymphocytes producing effector cytokines. Eur J Immunol 2008, 38:273-282.
14. +4 T cells with diverse cytokine profiles. Nat Med 2005, 11:1113-1117.
15. +4 T cells specific for defined antigens according to CD154 expression. Nat Med 2005, 11:1118-1124.
16. +4 T-cell responses by CD154 expression. Nat Protoc 2006, 1:1-6.
17. +4 T lymphocytes produce multiple cytokines and proliferate in vivo in humans. J Immunol 2006, 177:8185-8190.
18. +4 T cells. Cytometry A 2008, 73:1035-1042.
19. +4 T cells and protective memory against tuberculosis. Tuberculosis (Edinb) 2007, 87:465-473.
20. Barker L.F., Brennan M.J., Rosenstein P.K., Sadoff J.C. Tuberculosis vaccine research: the impact of immunology. Curr Opin Immunol 2009, 21:331-338.
21. Lindenstrøm T., Agger E.M., Korsholm K.S., Darrah P.A., Aagaard C., Seder R.A., et al. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 2009, 182:8047-8055.
22. Whelan A.O., Wright D.C., Chambers M.A., Singh M., Hewinson R.G., Vordermeier H.M. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations. Vaccine 2008, 26:166-173.
23. +4 memory T lymphocyte populations. Eur J Immunol 2007, 37:3089-3100.
24. Soares A.P., Scriba T.J., Joseph S., Harbacheuski R., Murray R.A., Gelderbloem S.J., et al. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 2008, 180:3569-3577.
25. +4, IFNgamma+, and TNFalpha+multifunctional memory T cells coexpress GM-CSF. Cytokine 2008, 43:143-148.
26. -4 T cells characterized by effector biomarker expression and anti-mycobacterial activity. Vaccine 2007, 25:8384-8394.
27. Martino A., Casetti R., Sacchi A., Poccia F. Central memory Vgamma9Vdelta2 T lymphocytes primed and expanded by bacillus Calmette-Guérin-infected dendritic cells kill mycobacterial-infected monocytes. J Immunol 2007, 179:3057-3064.
28. Trunz B.B., Fine P., Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006, 367:1173-1180.
29. Wherry E.J., Teichgraber V., Becker T.C., Masopust D., Kaech S.M., Antia R., et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003, 4:225-234.
30. Kaech S.M., Hemby S., Kersh E., Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 2002, 111:837-851.
31. Shin H., Wherry E.J. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 2007, 19:408-415.